TLR9 and metabolic dysfunction-associated steatohepatitis: In CDAA diet-induced NASH, TLR9-deficient mice showed reduced hepatic steatosis, inflammation, and fibrosis, and these differences mainly depended on IL-1β produced by KCs [17].